Abstract

A portable near-infrared spectral tomography (NIRST) system was developed with simultaneous frequency domain (FD) and continuous-wave (CW) optical measurements for efficient characterization of breast cancer in a clinical oncology setting. Simultaneous FD and CW recordings were implemented to speed up acquisition to 3 minutes for all 9 wavelengths, spanning a range from 661nm to 1064nm. An adjustable interface was designed to fit various breast sizes and shapes. Spatial images of oxy- and deoxy-hemoglobin, water, lipid, and scattering components were reconstructed using a 2D FEM approach. The system was tested on a group of 10 normal subjects, who were examined bilaterally and the recovered optical images were compared to radiographic breast density. Significantly higher total hemoglobin and water were estimated in the high density relative to low density groups. One patient with invasive ductal carcinoma was also examined and the cancer region was characterized as having a contrast ratio of 1.4 in total hemoglobin and 1.2 in water.

© 2016 Optical Society of America

Full Article  |  PDF Article
OSA Recommended Articles
A digital x-ray tomosynthesis coupled near infrared spectral tomography system for dual-modality breast imaging

Venkataramanan Krishnaswamy, Kelly E. Michaelsen, Brian W. Pogue, Steven P. Poplack, Ian Shaw, Ken Defrietas, Ken Brooks, and Keith D. Paulsen
Opt. Express 20(17) 19125-19136 (2012)

Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy monitored by dynamic tomographic optical breast imaging (DTOBI)

Amir Y. Sajjadi, Steven J. Isakoff, Bin Deng, Bhawana Singh, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, and Stefan A. Carp
Biomed. Opt. Express 8(2) 555-569 (2017)

Hemodynamic signature of breast cancer under fractional mammographic compression using a dynamic diffuse optical tomography system

Stefan A. Carp, Amir Y. Sajjadi, Christy M. Wanyo, Qianqian Fang, Michelle C. Specht, Lidia Schapira, Beverly Moy, Aditya Bardia, David A. Boas, and Steven J. Isakoff
Biomed. Opt. Express 4(12) 2911-2924 (2013)

References

  • View by:
  • |
  • |
  • |

  1. B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
    [PubMed]
  2. A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
    [Crossref] [PubMed]
  3. C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
    [Crossref] [PubMed]
  4. B. T. Miller, A. M. Abbott, and T. M. Tuttle, “The influence of preoperative MRI on breast cancer treatment,” Ann. Surg. Oncol. 19(2), 536–540 (2012).
    [Crossref] [PubMed]
  5. D. Groheux, S. Giacchetti, M. Espié, D. Rubello, J. L. Moretti, and E. Hindié, “Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 419–425 (2011).
    [Crossref] [PubMed]
  6. A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,” J. Biomed. Opt. 11(4), 044005 (2006).
    [Crossref] [PubMed]
  7. A. Corlu, R. Choe, T. Durduran, M. A. Rosen, M. Schweiger, S. R. Arridge, M. D. Schnall, and A. G. Yodh, “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Opt. Express 15(11), 6696–6716 (2007).
    [Crossref] [PubMed]
  8. S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
    [Crossref] [PubMed]
  9. S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
    [Crossref] [PubMed]
  10. M. Bartek, X. Wang, W. Wells, K. D. Paulsen, and B. W. Pogue, “Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue,” J. Biomed. Opt. 11(6), 064007 (2006).
    [Crossref] [PubMed]
  11. X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
    [Crossref] [PubMed]
  12. N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
    [Crossref] [PubMed]
  13. S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
    [Crossref] [PubMed]
  14. B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
    [Crossref] [PubMed]
  15. P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu, “Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm,” J. Biomed. Opt. 9(3), 464–473 (2004).
    [Crossref] [PubMed]
  16. B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
    [Crossref] [PubMed]
  17. V. Ntziachristos, A. G. Yodh, M. D. Schnall, and B. Chance, “MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions,” Neoplasia 4(4), 347–354 (2002).
    [Crossref] [PubMed]
  18. A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
    [Crossref] [PubMed]
  19. C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
    [Crossref] [PubMed]
  20. Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
    [Crossref] [PubMed]
  21. H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
    [Crossref] [PubMed]
  22. D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
    [Crossref] [PubMed]
  23. R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
    [Crossref] [PubMed]
  24. S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
    [Crossref] [PubMed]
  25. H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
    [Crossref] [PubMed]
  26. H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
    [PubMed]
  27. R. A. De Blasi, S. Fantini, M. A. Franceschini, M. Ferrari, and E. Gratton, “Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer,” Med. Biol. Eng. Comput. 33(2), 228–230 (1995).
    [Crossref] [PubMed]
  28. T. J. Farrell, M. S. Patterson, and B. Wilson, “A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo,” Med. Phys. 19(4), 879–888 (1992).
    [Crossref] [PubMed]
  29. C. D’Andrea, L. Spinelli, A. Bassi, A. Giusto, D. Contini, J. Swartling, A. Torricelli, and R. Cubeddu, “Time-resolved spectrally constrained method for the quantification of chromophore concentrations and scattering parameters in diffusing media,” Opt. Express 14(5), 1888–1898 (2006).
    [Crossref] [PubMed]
  30. P. Taroni, D. Comelli, A. Pifferi, A. Torricelli, and R. Cubeddu, “Absorption of collagen: effects on the estimate of breast composition and related diagnostic implications,” J. Biomed. Opt. 12(1), 014021 (2007).
    [Crossref] [PubMed]
  31. Y. Zhao, M. A. Mastanduno, S. Jiang, F. El-Ghussein, J. Xu, J. Gui, B. W. Pogue, and K. D. Paulsen, “Systematic optimization of MRI guided near infrared diffuse optical spectroscopy in breast,” in SPIE BiOS(International Society for Optics and Photonics2015), pp. 931605–931605–931608.
  32. Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
    [Crossref] [PubMed]
  33. J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
    [Crossref] [PubMed]
  34. F. El-Ghussein, M. A. Mastanduno, S. Jiang, B. W. Pogue, and K. D. Paulsen, “Hybrid photomultiplier tube and photodiode parallel detection array for wideband optical spectroscopy of the breast guided by magnetic resonance imaging,” J. Biomed. Opt. 19(1), 011010 (2013).
    [Crossref] [PubMed]
  35. S. Jiang, B. W. Pogue, A. M. Laughney, C. A. Kogel, and K. D. Paulsen, “Measurement of pressure-displacement kinetics of hemoglobin in normal breast tissue with near-infrared spectral imaging,” Appl. Opt. 48(10), D130–D136 (2009).
    [Crossref] [PubMed]
  36. M. A. Mastanduno, S. Jiang, R. Diflorio-Alexander, B. W. Pogue, and K. D. Paulsen, “Automatic and robust calibration of optical detector arrays for biomedical diffuse optical spectroscopy,” Biomed. Opt. Express 3(10), 2339–2352 (2012).
    [Crossref] [PubMed]
  37. H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
    [Crossref] [PubMed]
  38. M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
    [Crossref] [PubMed]
  39. N. Shah, A. E. Cerussi, D. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, “Spatial variations in optical and physiological properties of healthy breast tissue,” J. Biomed. Opt. 9(3), 534–540 (2004).
    [Crossref] [PubMed]
  40. D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
    [Crossref] [PubMed]
  41. L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. M. Danesini, and R. Cubeddu, “Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography,” J. Biomed. Opt. 9(6), 1137–1142 (2004).
    [Crossref] [PubMed]
  42. X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Acad. Radiol. 11(1), 53–60 (2004).
    [Crossref] [PubMed]
  43. Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
    [Crossref] [PubMed]
  44. M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
    [Crossref] [PubMed]
  45. A. M. Shannon, D. J. Bouchier-Hayes, C. M. Condron, and D. Toomey, “Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies,” Cancer Treat. Rev. 29(4), 297–307 (2003).
    [Crossref] [PubMed]

2015 (2)

Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

2014 (2)

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

2013 (2)

F. El-Ghussein, M. A. Mastanduno, S. Jiang, B. W. Pogue, and K. D. Paulsen, “Hybrid photomultiplier tube and photodiode parallel detection array for wideband optical spectroscopy of the breast guided by magnetic resonance imaging,” J. Biomed. Opt. 19(1), 011010 (2013).
[Crossref] [PubMed]

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

2012 (2)

2011 (3)

D. Groheux, S. Giacchetti, M. Espié, D. Rubello, J. L. Moretti, and E. Hindié, “Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 419–425 (2011).
[Crossref] [PubMed]

C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
[Crossref] [PubMed]

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

2010 (2)

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

2009 (3)

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, A. M. Laughney, C. A. Kogel, and K. D. Paulsen, “Measurement of pressure-displacement kinetics of hemoglobin in normal breast tissue with near-infrared spectral imaging,” Appl. Opt. 48(10), D130–D136 (2009).
[Crossref] [PubMed]

2008 (1)

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

2007 (4)

A. Corlu, R. Choe, T. Durduran, M. A. Rosen, M. Schweiger, S. R. Arridge, M. D. Schnall, and A. G. Yodh, “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Opt. Express 15(11), 6696–6716 (2007).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

P. Taroni, D. Comelli, A. Pifferi, A. Torricelli, and R. Cubeddu, “Absorption of collagen: effects on the estimate of breast composition and related diagnostic implications,” J. Biomed. Opt. 12(1), 014021 (2007).
[Crossref] [PubMed]

2006 (5)

A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,” J. Biomed. Opt. 11(4), 044005 (2006).
[Crossref] [PubMed]

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

M. Bartek, X. Wang, W. Wells, K. D. Paulsen, and B. W. Pogue, “Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue,” J. Biomed. Opt. 11(6), 064007 (2006).
[Crossref] [PubMed]

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

C. D’Andrea, L. Spinelli, A. Bassi, A. Giusto, D. Contini, J. Swartling, A. Torricelli, and R. Cubeddu, “Time-resolved spectrally constrained method for the quantification of chromophore concentrations and scattering parameters in diffusing media,” Opt. Express 14(5), 1888–1898 (2006).
[Crossref] [PubMed]

2005 (2)

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

2004 (5)

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu, “Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm,” J. Biomed. Opt. 9(3), 464–473 (2004).
[Crossref] [PubMed]

N. Shah, A. E. Cerussi, D. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, “Spatial variations in optical and physiological properties of healthy breast tissue,” J. Biomed. Opt. 9(3), 534–540 (2004).
[Crossref] [PubMed]

L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. M. Danesini, and R. Cubeddu, “Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography,” J. Biomed. Opt. 9(6), 1137–1142 (2004).
[Crossref] [PubMed]

X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Acad. Radiol. 11(1), 53–60 (2004).
[Crossref] [PubMed]

2003 (2)

A. M. Shannon, D. J. Bouchier-Hayes, C. M. Condron, and D. Toomey, “Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies,” Cancer Treat. Rev. 29(4), 297–307 (2003).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

2002 (1)

V. Ntziachristos, A. G. Yodh, M. D. Schnall, and B. Chance, “MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions,” Neoplasia 4(4), 347–354 (2002).
[Crossref] [PubMed]

2001 (2)

B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
[Crossref] [PubMed]

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

2000 (1)

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

1999 (2)

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

1997 (1)

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

1995 (1)

R. A. De Blasi, S. Fantini, M. A. Franceschini, M. Ferrari, and E. Gratton, “Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer,” Med. Biol. Eng. Comput. 33(2), 228–230 (1995).
[Crossref] [PubMed]

1992 (1)

T. J. Farrell, M. S. Patterson, and B. Wilson, “A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo,” Med. Phys. 19(4), 879–888 (1992).
[Crossref] [PubMed]

Abbott, A. M.

B. T. Miller, A. M. Abbott, and T. M. Tuttle, “The influence of preoperative MRI on breast cancer treatment,” Ann. Surg. Oncol. 19(2), 536–540 (2012).
[Crossref] [PubMed]

Ames, F. C.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Arridge, S. R.

A. Corlu, R. Choe, T. Durduran, M. A. Rosen, M. Schweiger, S. R. Arridge, M. D. Schnall, and A. G. Yodh, “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Opt. Express 15(11), 6696–6716 (2007).
[Crossref] [PubMed]

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Athanasiou, T.

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Babiera, G. V.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

Bartek, M.

M. Bartek, X. Wang, W. Wells, K. D. Paulsen, and B. W. Pogue, “Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue,” J. Biomed. Opt. 11(6), 064007 (2006).
[Crossref] [PubMed]

Barth, R. J.

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

Bartlett, M.

X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Acad. Radiol. 11(1), 53–60 (2004).
[Crossref] [PubMed]

Bassi, A.

Binkley, S. M.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Boas, D. A.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Bouchier-Hayes, D. J.

A. M. Shannon, D. J. Bouchier-Hayes, C. M. Condron, and D. Toomey, “Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies,” Cancer Treat. Rev. 29(4), 297–307 (2003).
[Crossref] [PubMed]

Breslin, T. M.

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

Brooksby, B. A.

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

Brown, A.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Brukilacchio, T. J.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Buchholz, T. A.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Butler, J.

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,” J. Biomed. Opt. 11(4), 044005 (2006).
[Crossref] [PubMed]

N. Shah, A. E. Cerussi, D. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, “Spatial variations in optical and physiological properties of healthy breast tissue,” J. Biomed. Opt. 9(3), 534–540 (2004).
[Crossref] [PubMed]

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

Butler, J. A.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Buzdar, A. U.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

Carpenter, C. M.

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Cerussi, A.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,” J. Biomed. Opt. 11(4), 044005 (2006).
[Crossref] [PubMed]

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

Cerussi, A. E.

N. Shah, A. E. Cerussi, D. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, “Spatial variations in optical and physiological properties of healthy breast tissue,” J. Biomed. Opt. 9(3), 534–540 (2004).
[Crossref] [PubMed]

Chagpar, A. B.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

Chance, B.

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

V. Ntziachristos, A. G. Yodh, M. D. Schnall, and B. Chance, “MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions,” Neoplasia 4(4), 347–354 (2002).
[Crossref] [PubMed]

Chaves, T.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Chen, W.-P.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Choe, R.

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

A. Corlu, R. Choe, T. Durduran, M. A. Rosen, M. Schweiger, S. R. Arridge, M. D. Schnall, and A. G. Yodh, “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Opt. Express 15(11), 6696–6716 (2007).
[Crossref] [PubMed]

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Chorlton, M.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Comelli, D.

P. Taroni, D. Comelli, A. Pifferi, A. Torricelli, and R. Cubeddu, “Absorption of collagen: effects on the estimate of breast composition and related diagnostic implications,” J. Biomed. Opt. 12(1), 014021 (2007).
[Crossref] [PubMed]

Condron, C. M.

A. M. Shannon, D. J. Bouchier-Hayes, C. M. Condron, and D. Toomey, “Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies,” Cancer Treat. Rev. 29(4), 297–307 (2003).
[Crossref] [PubMed]

Contini, D.

Corlu, A.

A. Corlu, R. Choe, T. Durduran, M. A. Rosen, M. Schweiger, S. R. Arridge, M. D. Schnall, and A. G. Yodh, “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Opt. Express 15(11), 6696–6716 (2007).
[Crossref] [PubMed]

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Cronin, E. B.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Cruz, A. B.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Cubeddu, R.

P. Taroni, D. Comelli, A. Pifferi, A. Torricelli, and R. Cubeddu, “Absorption of collagen: effects on the estimate of breast composition and related diagnostic implications,” J. Biomed. Opt. 12(1), 014021 (2007).
[Crossref] [PubMed]

C. D’Andrea, L. Spinelli, A. Bassi, A. Giusto, D. Contini, J. Swartling, A. Torricelli, and R. Cubeddu, “Time-resolved spectrally constrained method for the quantification of chromophore concentrations and scattering parameters in diffusing media,” Opt. Express 14(5), 1888–1898 (2006).
[Crossref] [PubMed]

L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. M. Danesini, and R. Cubeddu, “Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography,” J. Biomed. Opt. 9(6), 1137–1142 (2004).
[Crossref] [PubMed]

P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu, “Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm,” J. Biomed. Opt. 9(3), 464–473 (2004).
[Crossref] [PubMed]

Czarnota, G. J.

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

Czerniecki, B. J.

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

D’Andrea, C.

Danesini, G.

P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu, “Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm,” J. Biomed. Opt. 9(3), 464–473 (2004).
[Crossref] [PubMed]

Danesini, G. M.

L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. M. Danesini, and R. Cubeddu, “Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography,” J. Biomed. Opt. 9(6), 1137–1142 (2004).
[Crossref] [PubMed]

Darzi, A.

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Davis, S. C.

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

De Blasi, R. A.

R. A. De Blasi, S. Fantini, M. A. Franceschini, M. Ferrari, and E. Gratton, “Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer,” Med. Biol. Eng. Comput. 33(2), 228–230 (1995).
[Crossref] [PubMed]

DeCillis, A.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

DeFusco, P. A.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Dehghani, H.

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

DeMichele, A.

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Dempsey, P.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

Dent, R.

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

Dhingra, K.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

DiFlorio-Alexander, R.

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

M. A. Mastanduno, S. Jiang, R. Diflorio-Alexander, B. W. Pogue, and K. D. Paulsen, “Automatic and robust calibration of optical detector arrays for biomedical diffuse optical spectroscopy,” Biomed. Opt. Express 3(10), 2339–2352 (2012).
[Crossref] [PubMed]

diFlorio-Alexander, R. M.

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

Dimitrov, N. V.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Durduran, T.

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

A. Corlu, R. Choe, T. Durduran, M. A. Rosen, M. Schweiger, S. R. Arridge, M. D. Schnall, and A. G. Yodh, “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Opt. Express 15(11), 6696–6716 (2007).
[Crossref] [PubMed]

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Durkin, A.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,” J. Biomed. Opt. 11(4), 044005 (2006).
[Crossref] [PubMed]

Eames, M. E.

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

Ei-Ghussein, F.

Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
[Crossref] [PubMed]

Eker, C.

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

El-Ghussein, F.

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

F. El-Ghussein, M. A. Mastanduno, S. Jiang, B. W. Pogue, and K. D. Paulsen, “Hybrid photomultiplier tube and photodiode parallel detection array for wideband optical spectroscopy of the breast guided by magnetic resonance imaging,” J. Biomed. Opt. 19(1), 011010 (2013).
[Crossref] [PubMed]

Enfield, L. C.

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Espié, M.

D. Groheux, S. Giacchetti, M. Espié, D. Rubello, J. L. Moretti, and E. Hindié, “Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 419–425 (2011).
[Crossref] [PubMed]

Espinoza, J.

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

Fajardo, L. L.

X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Acad. Radiol. 11(1), 53–60 (2004).
[Crossref] [PubMed]

Fantini, S.

R. A. De Blasi, S. Fantini, M. A. Franceschini, M. Ferrari, and E. Gratton, “Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer,” Med. Biol. Eng. Comput. 33(2), 228–230 (1995).
[Crossref] [PubMed]

Farrell, T. J.

T. J. Farrell, M. S. Patterson, and B. Wilson, “A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo,” Med. Phys. 19(4), 879–888 (1992).
[Crossref] [PubMed]

Feig, B. W.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

Ferrari, M.

R. A. De Blasi, S. Fantini, M. A. Franceschini, M. Ferrari, and E. Gratton, “Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer,” Med. Biol. Eng. Comput. 33(2), 228–230 (1995).
[Crossref] [PubMed]

Fisher, B.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Fisher, E. R.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Fishkin, J.

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

Forero, J. A.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Fraker, D. L.

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Franceschini, M. A.

R. A. De Blasi, S. Fantini, M. A. Franceschini, M. Ferrari, and E. Gratton, “Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer,” Med. Biol. Eng. Comput. 33(2), 228–230 (1995).
[Crossref] [PubMed]

Frazee, T. E.

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

Giacchetti, S.

D. Groheux, S. Giacchetti, M. Espié, D. Rubello, J. L. Moretti, and E. Hindié, “Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 419–425 (2011).
[Crossref] [PubMed]

Gibson, A.

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Gibson, J. J.

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

Gilhuijs, K. G.

C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
[Crossref] [PubMed]

Giusto, A.

Gratton, E.

R. A. De Blasi, S. Fantini, M. A. Franceschini, M. Ferrari, and E. Gratton, “Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer,” Med. Biol. Eng. Comput. 33(2), 228–230 (1995).
[Crossref] [PubMed]

Groheux, D.

D. Groheux, S. Giacchetti, M. Espié, D. Rubello, J. L. Moretti, and E. Hindié, “Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 419–425 (2011).
[Crossref] [PubMed]

Grosicka-Koptyra, M.

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Grove, M. R.

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

Gu, X.

X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Acad. Radiol. 11(1), 53–60 (2004).
[Crossref] [PubMed]

Gui, J.

Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

Gunasekara, A.

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

Hart, J.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Hartov, A.

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

Hebden, J.

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Hegde, P. U.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Hillman, E.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Hindié, E.

D. Groheux, S. Giacchetti, M. Espié, D. Rubello, J. L. Moretti, and E. Hindié, “Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 419–425 (2011).
[Crossref] [PubMed]

Hoehn, J. L.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Hornung, R.

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

Hortobagyi, G. N.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

Hsiang, D.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,” J. Biomed. Opt. 11(4), 044005 (2006).
[Crossref] [PubMed]

N. Shah, A. E. Cerussi, D. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, “Spatial variations in optical and physiological properties of healthy breast tissue,” J. Biomed. Opt. 9(3), 534–540 (2004).
[Crossref] [PubMed]

Hunt, K. K.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

Jakubowski, D.

N. Shah, A. E. Cerussi, D. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, “Spatial variations in optical and physiological properties of healthy breast tissue,” J. Biomed. Opt. 9(3), 534–540 (2004).
[Crossref] [PubMed]

Jermyn, M.

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

Jiang, H.

X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Acad. Radiol. 11(1), 53–60 (2004).
[Crossref] [PubMed]

Jiang, S.

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

F. El-Ghussein, M. A. Mastanduno, S. Jiang, B. W. Pogue, and K. D. Paulsen, “Hybrid photomultiplier tube and photodiode parallel detection array for wideband optical spectroscopy of the breast guided by magnetic resonance imaging,” J. Biomed. Opt. 19(1), 011010 (2013).
[Crossref] [PubMed]

M. A. Mastanduno, S. Jiang, R. Diflorio-Alexander, B. W. Pogue, and K. D. Paulsen, “Automatic and robust calibration of optical detector arrays for biomedical diffuse optical spectroscopy,” Biomed. Opt. Express 3(10), 2339–2352 (2012).
[Crossref] [PubMed]

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, A. M. Laughney, C. A. Kogel, and K. D. Paulsen, “Measurement of pressure-displacement kinetics of hemoglobin in normal breast tissue with near-infrared spectral imaging,” Appl. Opt. 48(10), D130–D136 (2009).
[Crossref] [PubMed]

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

Kane, M.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Kaufman, P. A.

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Kogel, C.

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

Kogel, C. A.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, A. M. Laughney, C. A. Kogel, and K. D. Paulsen, “Measurement of pressure-displacement kinetics of hemoglobin in normal breast tissue with near-infrared spectral imaging,” Appl. Opt. 48(10), D130–D136 (2009).
[Crossref] [PubMed]

Konecky, S. D.

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Kopans, D. B.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Kuerer, H. M.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Lanning, R.

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

Laughney, A. M.

Lee, K.

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Lees, A. W.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Leff, D. R.

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Li, A.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Li, Z.

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

Loo, C. E.

C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
[Crossref] [PubMed]

Mamounas, E.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Margolese, R. G.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Mastanduno, M. A.

Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

F. El-Ghussein, M. A. Mastanduno, S. Jiang, B. W. Pogue, and K. D. Paulsen, “Hybrid photomultiplier tube and photodiode parallel detection array for wideband optical spectroscopy of the breast guided by magnetic resonance imaging,” J. Biomed. Opt. 19(1), 011010 (2013).
[Crossref] [PubMed]

M. A. Mastanduno, S. Jiang, R. Diflorio-Alexander, B. W. Pogue, and K. D. Paulsen, “Automatic and robust calibration of optical detector arrays for biomedical diffuse optical spectroscopy,” Biomed. Opt. Express 3(10), 2339–2352 (2012).
[Crossref] [PubMed]

McBride, T. O.

B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
[Crossref] [PubMed]

McLaren, C.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

McNeese, M. D.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Meaney, P. M.

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

Mehta, R.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

Meric-Bernstam, F.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

Michaelsen, K. E.

Middleton, L. P.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

Miller, B. T.

B. T. Miller, A. M. Abbott, and T. M. Tuttle, “The influence of preoperative MRI on breast cancer treatment,” Ann. Surg. Oncol. 19(2), 536–540 (2012).
[Crossref] [PubMed]

Mirza, A. N.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

Moore, R. H.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Moretti, J. L.

D. Groheux, S. Giacchetti, M. Espié, D. Rubello, J. L. Moretti, and E. Hindié, “Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 419–425 (2011).
[Crossref] [PubMed]

Muffly, L. S.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Muller, S. H.

C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
[Crossref] [PubMed]

Newman, L. A.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

Ntziachristos, V.

V. Ntziachristos, A. G. Yodh, M. D. Schnall, and B. Chance, “MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions,” Neoplasia 4(4), 347–354 (2002).
[Crossref] [PubMed]

Osterberg, U. L.

B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
[Crossref] [PubMed]

Osterman, K. S.

B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
[Crossref] [PubMed]

Patten, D. K.

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Patterson, M. S.

T. J. Farrell, M. S. Patterson, and B. Wilson, “A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo,” Med. Phys. 19(4), 879–888 (1992).
[Crossref] [PubMed]

Paulsen, K. D.

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

F. El-Ghussein, M. A. Mastanduno, S. Jiang, B. W. Pogue, and K. D. Paulsen, “Hybrid photomultiplier tube and photodiode parallel detection array for wideband optical spectroscopy of the breast guided by magnetic resonance imaging,” J. Biomed. Opt. 19(1), 011010 (2013).
[Crossref] [PubMed]

M. A. Mastanduno, S. Jiang, R. Diflorio-Alexander, B. W. Pogue, and K. D. Paulsen, “Automatic and robust calibration of optical detector arrays for biomedical diffuse optical spectroscopy,” Biomed. Opt. Express 3(10), 2339–2352 (2012).
[Crossref] [PubMed]

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, A. M. Laughney, C. A. Kogel, and K. D. Paulsen, “Measurement of pressure-displacement kinetics of hemoglobin in normal breast tissue with near-infrared spectral imaging,” Appl. Opt. 48(10), D130–D136 (2009).
[Crossref] [PubMed]

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

M. Bartek, X. Wang, W. Wells, K. D. Paulsen, and B. W. Pogue, “Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue,” J. Biomed. Opt. 11(6), 064007 (2006).
[Crossref] [PubMed]

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
[Crossref] [PubMed]

Pham, T.

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

Pifferi, A.

P. Taroni, D. Comelli, A. Pifferi, A. Torricelli, and R. Cubeddu, “Absorption of collagen: effects on the estimate of breast composition and related diagnostic implications,” J. Biomed. Opt. 12(1), 014021 (2007).
[Crossref] [PubMed]

P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu, “Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm,” J. Biomed. Opt. 9(3), 464–473 (2004).
[Crossref] [PubMed]

L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. M. Danesini, and R. Cubeddu, “Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography,” J. Biomed. Opt. 9(6), 1137–1142 (2004).
[Crossref] [PubMed]

Pogue, B. W.

Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

F. El-Ghussein, M. A. Mastanduno, S. Jiang, B. W. Pogue, and K. D. Paulsen, “Hybrid photomultiplier tube and photodiode parallel detection array for wideband optical spectroscopy of the breast guided by magnetic resonance imaging,” J. Biomed. Opt. 19(1), 011010 (2013).
[Crossref] [PubMed]

M. A. Mastanduno, S. Jiang, R. Diflorio-Alexander, B. W. Pogue, and K. D. Paulsen, “Automatic and robust calibration of optical detector arrays for biomedical diffuse optical spectroscopy,” Biomed. Opt. Express 3(10), 2339–2352 (2012).
[Crossref] [PubMed]

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, A. M. Laughney, C. A. Kogel, and K. D. Paulsen, “Measurement of pressure-displacement kinetics of hemoglobin in normal breast tissue with near-infrared spectral imaging,” Appl. Opt. 48(10), D130–D136 (2009).
[Crossref] [PubMed]

M. Bartek, X. Wang, W. Wells, K. D. Paulsen, and B. W. Pogue, “Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue,” J. Biomed. Opt. 11(6), 064007 (2006).
[Crossref] [PubMed]

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
[Crossref] [PubMed]

Poplack, S. P.

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
[Crossref] [PubMed]

Rafferty, E.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Ren, F.

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

Ricci, A.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Robidoux, A.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Roblyer, D.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Rodenhuis, S.

C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
[Crossref] [PubMed]

Rosen, M. A.

A. Corlu, R. Choe, T. Durduran, M. A. Rosen, M. Schweiger, S. R. Arridge, M. D. Schnall, and A. G. Yodh, “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Opt. Express 15(11), 6696–6716 (2007).
[Crossref] [PubMed]

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

Ross, M. I.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Rubello, D.

D. Groheux, S. Giacchetti, M. Espié, D. Rubello, J. L. Moretti, and E. Hindié, “Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 419–425 (2011).
[Crossref] [PubMed]

Rycroft, M.

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

Sahin, A. A.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

Schnall, M. D.

Schutz, L.

X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Acad. Radiol. 11(1), 53–60 (2004).
[Crossref] [PubMed]

Schwartz, G. N.

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Schweiger, M.

Shah, N.

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,” J. Biomed. Opt. 11(4), 044005 (2006).
[Crossref] [PubMed]

N. Shah, A. E. Cerussi, D. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, “Spatial variations in optical and physiological properties of healthy breast tissue,” J. Biomed. Opt. 9(3), 534–540 (2004).
[Crossref] [PubMed]

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

Shannon, A. M.

A. M. Shannon, D. J. Bouchier-Hayes, C. M. Condron, and D. Toomey, “Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies,” Cancer Treat. Rev. 29(4), 297–307 (2003).
[Crossref] [PubMed]

Singh, G.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Singletary, S. E.

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

Smith, T. L.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Sneige, N.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Soho, S.

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

Soho, S. K.

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

Soliman, H.

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

Song, X.

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

Spayne, J.

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

Spinelli, L.

C. D’Andrea, L. Spinelli, A. Bassi, A. Giusto, D. Contini, J. Swartling, A. Torricelli, and R. Cubeddu, “Time-resolved spectrally constrained method for the quantification of chromophore concentrations and scattering parameters in diffusing media,” Opt. Express 14(5), 1888–1898 (2006).
[Crossref] [PubMed]

L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. M. Danesini, and R. Cubeddu, “Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography,” J. Biomed. Opt. 9(6), 1137–1142 (2004).
[Crossref] [PubMed]

P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu, “Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm,” J. Biomed. Opt. 9(3), 464–473 (2004).
[Crossref] [PubMed]

Srinivasan, S.

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

Stott, J. J.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Straver, M. E.

C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
[Crossref] [PubMed]

Svaasand, L.

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

Swartling, J.

Tanamai, W.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Tannenbaum, S. H.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Taroni, P.

P. Taroni, D. Comelli, A. Pifferi, A. Torricelli, and R. Cubeddu, “Absorption of collagen: effects on the estimate of breast composition and related diagnostic implications,” J. Biomed. Opt. 12(1), 014021 (2007).
[Crossref] [PubMed]

P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu, “Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm,” J. Biomed. Opt. 9(3), 464–473 (2004).
[Crossref] [PubMed]

L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. M. Danesini, and R. Cubeddu, “Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography,” J. Biomed. Opt. 9(6), 1137–1142 (2004).
[Crossref] [PubMed]

Tavakoli, B.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Theriault, R. L.

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

Toomey, D.

A. M. Shannon, D. J. Bouchier-Hayes, C. M. Condron, and D. Toomey, “Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies,” Cancer Treat. Rev. 29(4), 297–307 (2003).
[Crossref] [PubMed]

Torricelli, A.

P. Taroni, D. Comelli, A. Pifferi, A. Torricelli, and R. Cubeddu, “Absorption of collagen: effects on the estimate of breast composition and related diagnostic implications,” J. Biomed. Opt. 12(1), 014021 (2007).
[Crossref] [PubMed]

C. D’Andrea, L. Spinelli, A. Bassi, A. Giusto, D. Contini, J. Swartling, A. Torricelli, and R. Cubeddu, “Time-resolved spectrally constrained method for the quantification of chromophore concentrations and scattering parameters in diffusing media,” Opt. Express 14(5), 1888–1898 (2006).
[Crossref] [PubMed]

L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. M. Danesini, and R. Cubeddu, “Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography,” J. Biomed. Opt. 9(6), 1137–1142 (2004).
[Crossref] [PubMed]

P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu, “Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm,” J. Biomed. Opt. 9(3), 464–473 (2004).
[Crossref] [PubMed]

Tosteson, T. D.

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

Tromberg, B.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

Tromberg, B. J.

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,” J. Biomed. Opt. 11(4), 044005 (2006).
[Crossref] [PubMed]

N. Shah, A. E. Cerussi, D. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, “Spatial variations in optical and physiological properties of healthy breast tissue,” J. Biomed. Opt. 9(3), 534–540 (2004).
[Crossref] [PubMed]

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

Tuttle, T. M.

B. T. Miller, A. M. Abbott, and T. M. Tuttle, “The influence of preoperative MRI on breast cancer treatment,” Ann. Surg. Oncol. 19(2), 536–540 (2012).
[Crossref] [PubMed]

Ueda, S.

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

Vrancken Peeters, M. J.

C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
[Crossref] [PubMed]

Wang, J.

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

Wang, K.

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

Wang, X.

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

M. Bartek, X. Wang, W. Wells, K. D. Paulsen, and B. W. Pogue, “Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue,” J. Biomed. Opt. 11(6), 064007 (2006).
[Crossref] [PubMed]

Warren, O. J.

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Wells, W.

M. Bartek, X. Wang, W. Wells, K. D. Paulsen, and B. W. Pogue, “Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue,” J. Biomed. Opt. 11(6), 064007 (2006).
[Crossref] [PubMed]

Wells, W. A.

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
[Crossref] [PubMed]

Wesseling, J.

C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
[Crossref] [PubMed]

Wickerham, D. L.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Wieand, S.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Wilson, B.

T. J. Farrell, M. S. Patterson, and B. Wilson, “A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo,” Med. Phys. 19(4), 879–888 (1992).
[Crossref] [PubMed]

Wolmark, N.

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Wu, T.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

Xu, J.

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

Xu, Y.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Yaffe, M. J.

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

Yalavarthy, P. K.

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

Yang, G. Z.

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Yin, H.

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

Yodh, A. G.

A. Corlu, R. Choe, T. Durduran, M. A. Rosen, M. Schweiger, S. R. Arridge, M. D. Schnall, and A. G. Yodh, “Three-dimensional in vivo fluorescence diffuse optical tomography of breast cancer in humans,” Opt. Express 15(11), 6696–6716 (2007).
[Crossref] [PubMed]

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

V. Ntziachristos, A. G. Yodh, M. D. Schnall, and B. Chance, “MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions,” Neoplasia 4(4), 347–354 (2002).
[Crossref] [PubMed]

Yu, G.

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

Zhang, Q.

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Acad. Radiol. 11(1), 53–60 (2004).
[Crossref] [PubMed]

Zhao, Y.

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
[Crossref] [PubMed]

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. E. Michaelsen, K. Wang, F. Ren, B. W. Pogue, and K. D. Paulsen, “Sensitivity of MRI-guided near-infrared spectroscopy clinical breast exam data and its impact on diagnostic performance,” Biomed. Opt. Express 5(9), 3103–3115 (2014).
[Crossref] [PubMed]

Zhou, C.

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

Zhu, Q.

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Zubovits, J.

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

Acad. Radiol. (1)

X. Gu, Q. Zhang, M. Bartlett, L. Schutz, L. L. Fajardo, and H. Jiang, “Differentiation of cysts from solid tumors in the breast with diffuse optical tomography,” Acad. Radiol. 11(1), 53–60 (2004).
[Crossref] [PubMed]

Ann. Surg. (2)

A. B. Chagpar, L. P. Middleton, A. A. Sahin, P. Dempsey, A. U. Buzdar, A. N. Mirza, F. C. Ames, G. V. Babiera, B. W. Feig, K. K. Hunt, H. M. Kuerer, F. Meric-Bernstam, M. I. Ross, and S. E. Singletary, “Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 243(2), 257–264 (2006).
[Crossref] [PubMed]

H. M. Kuerer, A. A. Sahin, K. K. Hunt, L. A. Newman, T. M. Breslin, F. C. Ames, M. I. Ross, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy,” Ann. Surg. 230(1), 72–78 (1999).
[Crossref] [PubMed]

Ann. Surg. Oncol. (1)

B. T. Miller, A. M. Abbott, and T. M. Tuttle, “The influence of preoperative MRI on breast cancer treatment,” Ann. Surg. Oncol. 19(2), 536–540 (2012).
[Crossref] [PubMed]

Appl. Opt. (1)

Biomed. Opt. Express (2)

Breast Cancer Res. Treat. (1)

D. R. Leff, O. J. Warren, L. C. Enfield, A. Gibson, T. Athanasiou, D. K. Patten, J. Hebden, G. Z. Yang, and A. Darzi, “Diffuse optical imaging of the healthy and diseased breast: a systematic review,” Breast Cancer Res. Treat. 108(1), 9–22 (2008).
[Crossref] [PubMed]

Cancer Treat. Rev. (1)

A. M. Shannon, D. J. Bouchier-Hayes, C. M. Condron, and D. Toomey, “Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies,” Cancer Treat. Rev. 29(4), 297–307 (2003).
[Crossref] [PubMed]

Clin. Cancer Res. (3)

M. A. Mastanduno, J. Xu, F. El-Ghussein, S. Jiang, H. Yin, Y. Zhao, K. Wang, F. Ren, J. Gui, B. W. Pogue, and K. D. Paulsen, “MR-Guided Near-Infrared Spectral Tomography Increases Diagnostic Performance of Breast MRI,” Clin. Cancer Res. 21(17), 3906–3912 (2015).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, P. A. Kaufman, J. Gui, M. Jermyn, T. E. Frazee, S. P. Poplack, R. DiFlorio-Alexander, W. A. Wells, and K. D. Paulsen, “Predicting breast tumor response to neoadjuvant chemotherapy with diffuse optical spectroscopic tomography prior to treatment,” Clin. Cancer Res. 20(23), 6006–6015 (2014).
[Crossref] [PubMed]

H. Soliman, A. Gunasekara, M. Rycroft, J. Zubovits, R. Dent, J. Spayne, M. J. Yaffe, and G. J. Czarnota, “Functional imaging using diffuse optical spectroscopy of neoadjuvant chemotherapy response in women with locally advanced breast cancer,” Clin. Cancer Res. 16(9), 2605–2614 (2010).
[Crossref] [PubMed]

Commun. Numer. Methods Eng. (1)

H. Dehghani, M. E. Eames, P. K. Yalavarthy, S. C. Davis, S. Srinivasan, C. M. Carpenter, B. W. Pogue, and K. D. Paulsen, “Near infrared optical tomography using NIRFAST: Algorithm for numerical model and image reconstruction,” Commun. Numer. Methods Eng. 25(6), 711–732 (2009).
[Crossref] [PubMed]

Eur. J. Nucl. Med. Mol. Imaging (1)

D. Groheux, S. Giacchetti, M. Espié, D. Rubello, J. L. Moretti, and E. Hindié, “Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim,” Eur. J. Nucl. Med. Mol. Imaging 38(3), 419–425 (2011).
[Crossref] [PubMed]

J. Biomed. Opt. (11)

A. Cerussi, N. Shah, D. Hsiang, A. Durkin, J. Butler, and B. J. Tromberg, “In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy,” J. Biomed. Opt. 11(4), 044005 (2006).
[Crossref] [PubMed]

M. Bartek, X. Wang, W. Wells, K. D. Paulsen, and B. W. Pogue, “Estimation of subcellular particle size histograms with electron microscopy for prediction of optical scattering in breast tissue,” J. Biomed. Opt. 11(6), 064007 (2006).
[Crossref] [PubMed]

X. Wang, B. W. Pogue, S. Jiang, H. Dehghani, X. Song, S. Srinivasan, B. A. Brooksby, K. D. Paulsen, C. Kogel, S. P. Poplack, and W. A. Wells, “Image reconstruction of effective Mie scattering parameters of breast tissue in vivo with near-infrared tomography,” J. Biomed. Opt. 11(4), 041106 (2006).
[Crossref] [PubMed]

P. Taroni, G. Danesini, A. Torricelli, A. Pifferi, L. Spinelli, and R. Cubeddu, “Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm,” J. Biomed. Opt. 9(3), 464–473 (2004).
[Crossref] [PubMed]

Y. Zhao, M. A. Mastanduno, S. Jiang, F. Ei-Ghussein, J. Gui, B. W. Pogue, and K. D. Paulsen, “Optimization of image reconstruction for magnetic resonance imaging-guided near-infrared diffuse optical spectroscopy in breast,” J. Biomed. Opt. 20(5), 056009 (2015).
[Crossref] [PubMed]

P. Taroni, D. Comelli, A. Pifferi, A. Torricelli, and R. Cubeddu, “Absorption of collagen: effects on the estimate of breast composition and related diagnostic implications,” J. Biomed. Opt. 12(1), 014021 (2007).
[Crossref] [PubMed]

C. Zhou, R. Choe, N. Shah, T. Durduran, G. Yu, A. Durkin, D. Hsiang, R. Mehta, J. Butler, A. Cerussi, B. J. Tromberg, and A. G. Yodh, “Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy,” J. Biomed. Opt. 12(5), 051903 (2007).
[Crossref] [PubMed]

N. Shah, A. E. Cerussi, D. Jakubowski, D. Hsiang, J. Butler, and B. J. Tromberg, “Spatial variations in optical and physiological properties of healthy breast tissue,” J. Biomed. Opt. 9(3), 534–540 (2004).
[Crossref] [PubMed]

L. Spinelli, A. Torricelli, A. Pifferi, P. Taroni, G. M. Danesini, and R. Cubeddu, “Bulk optical properties and tissue components in the female breast from multiwavelength time-resolved optical mammography,” J. Biomed. Opt. 9(6), 1137–1142 (2004).
[Crossref] [PubMed]

Q. Zhang, T. J. Brukilacchio, A. Li, J. J. Stott, T. Chaves, E. Hillman, T. Wu, M. Chorlton, E. Rafferty, R. H. Moore, D. B. Kopans, and D. A. Boas, “Coregistered tomographic x-ray and optical breast imaging: initial results,” J. Biomed. Opt. 10(2), 024033 (2005).
[Crossref] [PubMed]

F. El-Ghussein, M. A. Mastanduno, S. Jiang, B. W. Pogue, and K. D. Paulsen, “Hybrid photomultiplier tube and photodiode parallel detection array for wideband optical spectroscopy of the breast guided by magnetic resonance imaging,” J. Biomed. Opt. 19(1), 011010 (2013).
[Crossref] [PubMed]

J. Clin. Oncol. (3)

H. M. Kuerer, L. A. Newman, T. L. Smith, F. C. Ames, K. K. Hunt, K. Dhingra, R. L. Theriault, G. Singh, S. M. Binkley, N. Sneige, T. A. Buchholz, M. I. Ross, M. D. McNeese, A. U. Buzdar, G. N. Hortobagyi, and S. E. Singletary, “Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy,” J. Clin. Oncol. 17(2), 460–469 (1999).
[PubMed]

C. E. Loo, M. E. Straver, S. Rodenhuis, S. H. Muller, J. Wesseling, M. J. Vrancken Peeters, and K. G. Gilhuijs, “Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype,” J. Clin. Oncol. 29(6), 660–666 (2011).
[Crossref] [PubMed]

B. Fisher, A. Brown, E. Mamounas, S. Wieand, A. Robidoux, R. G. Margolese, A. B. Cruz, E. R. Fisher, D. L. Wickerham, N. Wolmark, A. DeCillis, J. L. Hoehn, A. W. Lees, and N. V. Dimitrov, “Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18,” J. Clin. Oncol. 15(7), 2483–2493 (1997).
[PubMed]

Med. Biol. Eng. Comput. (1)

R. A. De Blasi, S. Fantini, M. A. Franceschini, M. Ferrari, and E. Gratton, “Cerebral and muscle oxygen saturation measurement by frequency-domain near-infra-red spectrometer,” Med. Biol. Eng. Comput. 33(2), 228–230 (1995).
[Crossref] [PubMed]

Med. Phys. (3)

T. J. Farrell, M. S. Patterson, and B. Wilson, “A diffusion theory model of spatially resolved, steady-state diffuse reflectance for the noninvasive determination of tissue optical properties in vivo,” Med. Phys. 19(4), 879–888 (1992).
[Crossref] [PubMed]

R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, “Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI,” Med. Phys. 32(4), 1128–1139 (2005).
[Crossref] [PubMed]

J. Wang, S. Jiang, Z. Li, R. M. diFlorio-Alexander, R. J. Barth, P. A. Kaufman, B. W. Pogue, and K. D. Paulsen, “In vivo quantitative imaging of normal and cancerous breast tissue using broadband diffuse optical tomography,” Med. Phys. 37(7), 3715–3724 (2010).
[Crossref] [PubMed]

Neoplasia (2)

B. J. Tromberg, N. Shah, R. Lanning, A. Cerussi, J. Espinoza, T. Pham, L. Svaasand, and J. Butler, “Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy,” Neoplasia 2(1-2), 26–40 (2000).
[Crossref] [PubMed]

V. Ntziachristos, A. G. Yodh, M. D. Schnall, and B. Chance, “MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions,” Neoplasia 4(4), 347–354 (2002).
[Crossref] [PubMed]

Opt. Express (2)

Proc. Natl. Acad. Sci. U.S.A. (4)

D. Roblyer, S. Ueda, A. Cerussi, W. Tanamai, A. Durkin, R. Mehta, D. Hsiang, J. A. Butler, C. McLaren, W.-P. Chen, and B. Tromberg, “Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment,” Proc. Natl. Acad. Sci. U.S.A. 108(35), 14626–14631 (2011).
[Crossref] [PubMed]

N. Shah, A. Cerussi, C. Eker, J. Espinoza, J. Butler, J. Fishkin, R. Hornung, and B. Tromberg, “Noninvasive functional optical spectroscopy of human breast tissue,” Proc. Natl. Acad. Sci. U.S.A. 98(8), 4420–4425 (2001).
[Crossref] [PubMed]

S. Srinivasan, B. W. Pogue, S. Jiang, H. Dehghani, C. Kogel, S. Soho, J. J. Gibson, T. D. Tosteson, S. P. Poplack, and K. D. Paulsen, “Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography,” Proc. Natl. Acad. Sci. U.S.A. 100(21), 12349–12354 (2003).
[Crossref] [PubMed]

A. Cerussi, D. Hsiang, N. Shah, R. Mehta, A. Durkin, J. Butler, and B. J. Tromberg, “Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy,” Proc. Natl. Acad. Sci. U.S.A. 104(10), 4014–4019 (2007).
[Crossref] [PubMed]

Radiology (4)

B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. Osterberg, and K. D. Paulsen, “Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast,” Radiology 218(1), 261–266 (2001).
[Crossref] [PubMed]

S. P. Poplack, K. D. Paulsen, A. Hartov, P. M. Meaney, B. W. Pogue, T. D. Tosteson, M. R. Grove, S. K. Soho, and W. A. Wells, “Electromagnetic breast imaging: average tissue property values in women with negative clinical findings,” Radiology 231(2), 571–580 (2004).
[Crossref] [PubMed]

S. Jiang, B. W. Pogue, C. M. Carpenter, S. P. Poplack, W. A. Wells, C. A. Kogel, J. A. Forero, L. S. Muffly, G. N. Schwartz, K. D. Paulsen, and P. A. Kaufman, “Evaluation of breast tumor response to neoadjuvant chemotherapy with tomographic diffuse optical spectroscopy: case studies of tumor region-of-interest changes,” Radiology 252(2), 551–560 (2009).
[Crossref] [PubMed]

Q. Zhu, P. A. DeFusco, A. Ricci, E. B. Cronin, P. U. Hegde, M. Kane, B. Tavakoli, Y. Xu, J. Hart, and S. H. Tannenbaum, “Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography,” Radiology 266(2), 433–442 (2013).
[Crossref] [PubMed]

Other (1)

Y. Zhao, M. A. Mastanduno, S. Jiang, F. El-Ghussein, J. Xu, J. Gui, B. W. Pogue, and K. D. Paulsen, “Systematic optimization of MRI guided near infrared diffuse optical spectroscopy in breast,” in SPIE BiOS(International Society for Optics and Photonics2015), pp. 931605–931605–931608.

Cited By

OSA participates in Crossref's Cited-By Linking service. Citing articles from OSA journals and other participating publishers are listed here.

Alert me when this article is cited.


Figures (7)

Fig. 1
Fig. 1 FD + CW NIRST system. (a) The mobile unit with dimensions of 160cm × 63cm × 85cm. (b) Subject being imaged with the system. (c) Surface image of breast-interface.
Fig. 2
Fig. 2 System diagram for simultaneous acquisition. FD source module, CW source module, and data acquisition/processing module are highlighted in blue, green, and violet blocks, respectively. The flow of low frequency electrical signal, high frequency electrical signal, and light is shown by the black, blue and red solid lines, respectively.
Fig. 3
Fig. 3 Experimental setup and reconstructed optical images for two heterogeneous phantoms with 1 inch diameter inclusions. The corresponding interface had deep curvature (a) and flat curvature (b). For both phantoms, the blood concentrations inside and outside the inclusion were 1.5% and 1%, respectively. The interface separation was 75mm and 70mm for the curved and flat interface, respectively.
Fig. 4
Fig. 4 Continuous measurements of (a) HbT; (b) StO2; (c) water; (d) lipid; (e) SA and (f) SP for two normal subjects.
Fig. 5
Fig. 5 Recovered optical images of three normal subjects. Maximum separation between the two fiber holders in the interface was 63mm (a), 85mm (b), and 50mm (c), respectively.
Fig. 6
Fig. 6 Data from subjects grouped by mammographic breast density (five subjects per group). HbT: total hemoglobin; StO2: oxygen saturation; SA: scattering amplitude; SP: scattering power.
Fig. 7
Fig. 7 MRI T2 images of a patient with invasive cancer in the right breast: (a) Axial view, (b) sagittal view and (c) coronal view. Recovered optical images of HbT, StO2, water, lipid, SA, and SP for right (d) and left (e) breast, respectively. Recovered optical images are displayed in the same orientation in (d) as in (c).

Tables (1)

Tables Icon

Table 1 Mean, standard deviation and total range of physiological and optical parameters for 10 normal subjects

Equations (2)

Equations on this page are rendered with MathJax. Learn more.

D(r)Φ(r,ω)+( μ a (r)+iω/c )Φ(r,ω)= Q o (r,ω)
( J T J+ λ ¯ I ) 1 J T δΦ=δμ

Metrics